Dolby Laboratories, Inc. (DLB)

Dolby Laboratories Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 27, 2025	Sep 27, 2024	Sep 29, 2023	Sep 30, 2022	Sep 24, 2021	Sep 25, 2020
Cash & Equivalents	698.57	482.05	745.36	620.13	1,225	1,072
Short-Term Investments	0.76	-	139.15	189.21	38.84	46.95
Cash & Short-Term Investments	699.33	482.05	884.51	809.34	1,264	1,119
Cash Growth	-19.52%	-45.50%	9.29%	-35.98%	13.00%	22.10%
Accounts Receivable	502	512.94	444.38	419.69	414.93	341.7
Receivables	502	512.94	444.38	419.69	414.93	341.7
Inventory	32.42	33.73	35.62	23.55	10.97	25.55
Prepaid Expenses	26.25	29.75	24.44	26.85	29.96	17.88
Restricted Cash	58	95.71	72.6	8.24	7.65	8.1
Other Current Assets	20.13	40.25	26.26	23.22	32.77	35.14
Total Current Assets	1,338	1,194	1,488	1,311	1,760	1,547
Property, Plant & Equipment	511.43	518.16	521.78	560.01	601.51	618.48
Long-Term Investments	78.02	89.27	97.81	102.51	62.82	52.15
Goodwill	528.82	533.21	408.41	365.15	340.69	336.95
Other Intangible Assets	408.15	434.51	167.43	112.27	122.89	152.43
Long-Term Deferred Tax Assets	228.64	219.76	201.86	183.57	156.02	118.88
Other Long-Term Assets	102.82	120.61	94.67	55.15	61.26	91.25
Total Assets	3,196	3,110	2,980	2,690	3,106	2,917
Accounts Payable	17.23	17.38	20.93	14.17	17.78	12.62
Accrued Expenses	167.02	171.01	179.01	143.15	157.69	134.31
Current Portion of Leases	10.95	12.24	13.63	13.26	15.4	15.82
Current Income Taxes Payable	7.15	9.05	4.77	1.27	1.33	3.26
Current Unearned Revenue	36.03	31.64	31.51	18.59	18.47	15.44
Other Current Liabilities	150.4	176.52	172.39	87.09	105.03	85.66
Total Current Liabilities	388.79	417.84	422.23	277.52	315.72	267.11
Long-Term Leases	28.16	34.75	37.02	37.69	56.72	65.32
Long-Term Unearned Revenue	29.03	34.59	40	23.2	23.71	24.34
Other Long-Term Liabilities	130.79	130.91	104.04	96	100.43	117.97
Total Liabilities	581.75	623.04	607.58	438.53	501.46	478.92
Common Stock	0.09	0.09	0.09	0.09	0.1	0.1
Retained Earnings	2,618	2,496	2,392	2,298	2,608	2,443
Comprehensive Income & Other	-13.52	-19.19	-36.98	-51.64	-10.03	-10.59
Total Common Equity	2,605	2,477	2,355	2,246	2,598	2,433
Minority Interest	9.52	9.73	17.08	4.84	6.25	5.76
Shareholders' Equity	2,614	2,487	2,372	2,251	2,604	2,438
Total Liabilities & Equity	3,196	3,110	2,980	2,690	3,106	2,917
Total Debt	39.11	46.99	50.65	50.94	72.12	81.14
Net Cash (Debt)	660.22	435.06	833.86	758.4	1,192	1,038
Net Cash Growth	-19.56%	-47.83%	9.95%	-36.38%	14.88%	13.24%
Net Cash Per Share	6.78	4.47	8.53	7.44	11.39	10.08
Filing Date Shares Outstanding	95.84	95.44	95.28	95.96	101.16	100.35
Total Common Shares Outstanding	95.78	95.39	95.76	95.88	101.07	100.3
Working Capital	949.33	776.58	1,066	1,033	1,445	1,280
Book Value Per Share	27.19	25.97	24.59	23.43	25.70	24.25
Tangible Book Value	1,668	1,509	1,779	1,769	2,134	1,943
Tangible Book Value Per Share	17.41	15.82	18.58	18.45	21.12	19.38
Land	42.04	42.01	41.9	41.77	42.04	41.96
Buildings	290.95	288.91	287.8	287.54	284.15	283.62
Machinery	387.58	410.94	418.53	402.9	420.55	389.59
Construction In Progress	36.4	25.09	18.33	23.04	22.92	19.55
Leasehold Improvements	85.1	86.61	79.99	86.79	88.55	83.76

Updated May 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q